ARTICLE | Distillery Therapeutics
GSK3A inhibition restores asparaginase sensitivity in resistant ALL, AML
May 14, 2019 2:20 PM UTC
INDICATION: Acute lymphoblastic leukemia (ALL); acute myelogenous leukemia (AML)...
BCIQ Company Profiles
BCIQ Target Profiles